Fang Shawn Foo1, Mildred Lee1, David Heaven1, Nigel Lever2, Susan Sinclair2, Martin K Stiles3, Scott Harding4, Dean Boddington5, Peter Larsen6, Rod Jackson7, Andrew J Kerr8. 1. Department of Cardiology, Middlemore Hospital, Auckland. 2. Department of Cardiology, Auckland City Hospital, Auckland. 3. Department of Cardiology, Waikato Hospital, Hamilton. 4. Department of Cardiology, Wellington Hospital, Wellington. 5. Department of Cardiology, Tauranga Hospital, Tauranga. 6. Wellington Cardiovascular Research Group, Wellington Hospital, Wellington. 7. University of Auckland, Auckland. 8. Department of Cardiology, Middlemore Hospital, Auckland; University of Auckland, Auckland; on behalf of the ANZACS-QI investigators.
Abstract
AIMS: The ANZACS-QI Cardiac Implanted Device Registry (ANZACS-QI DEVICE) collects data on cardiac implantable electronic devices inserted in New Zealand. We evaluated completeness of data capture and quality of ANZACS-QI DEVICE in 2016. METHODS: Complete datasets within ANZACS-QI DEVICE, comprising DEVICE-PPM (permanent pacemakers) and DEVICE-ICD (implantable cardioverter defibrillators), from 1 January 2016 to 31 December 2016 were linked with the National Hospitalisation dataset (all New Zealand public hospital admissions). The total number of implants included procedures captured in either dataset. Variables assessed included age, gender, ethnicity, procedure type, implanting centre, admission and procedure date. RESULTS: DEVICE-PPM captured 85.9% of all PPM procedures (n=2,512). This was similar regardless of age, sex and ethnicity. In the 84.4% of procedures captured in both datasets, agreement was >97% for all variables except admission date (90.1%). DEVICE-ICD captured 81.3% of all ICD procedures (n=690). Capture was similar across age, sex and ethnicity groups. In the 76.8% of procedures captured in both datasets, agreement was >96% for all variables except admission date (90.6%). CONCLUSION: The ANZACS-QI DEVICE registry had a good capture rate and excellent agreement with the national dataset. This high concordance supports the use of both datasets for future research.
AIMS: The ANZACS-QI Cardiac Implanted Device Registry (ANZACS-QI DEVICE) collects data on cardiac implantable electronic devices inserted in New Zealand. We evaluated completeness of data capture and quality of ANZACS-QI DEVICE in 2016. METHODS: Complete datasets within ANZACS-QI DEVICE, comprising DEVICE-PPM (permanent pacemakers) and DEVICE-ICD (implantable cardioverter defibrillators), from 1 January 2016 to 31 December 2016 were linked with the National Hospitalisation dataset (all New Zealand public hospital admissions). The total number of implants included procedures captured in either dataset. Variables assessed included age, gender, ethnicity, procedure type, implanting centre, admission and procedure date. RESULTS: DEVICE-PPM captured 85.9% of all PPM procedures (n=2,512). This was similar regardless of age, sex and ethnicity. In the 84.4% of procedures captured in both datasets, agreement was >97% for all variables except admission date (90.1%). DEVICE-ICD captured 81.3% of all ICD procedures (n=690). Capture was similar across age, sex and ethnicity groups. In the 76.8% of procedures captured in both datasets, agreement was >96% for all variables except admission date (90.6%). CONCLUSION: The ANZACS-QI DEVICE registry had a good capture rate and excellent agreement with the national dataset. This high concordance supports the use of both datasets for future research.
Authors: Fang Shawn Foo; Mildred Lee; Khang-Li Looi; Peter Larsen; Geoffrey C Clare; David Heaven; Martin K Stiles; Jamie Voss; Dean Boddington; Rod Jackson; Andrew J Kerr Journal: J Arrhythm Date: 2019-10-06